FOLD vs HAL · rev $528.3M vs P/E 9.3, $19.05B cap
Amicus Therapeutics Inc (FOLD) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
HAL does not have a complete income-statement cache yet.
FOLD currently screens at market cap $1.80B. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the FOLD and HAL stock pages for the full models.
Not investment advice.